Note: This section contains information in English only.The biotech start-up Gossamer is set to launch a risky initial public offering, despite the US government shutdown, which froze stock market debuts, the company stated on Wednesday.
Thu, 24 Jan 2019 10:27:43 GMT
Source: Dukascopy Bank SA